Seminar “Optimization of immunooncology drug discovery using mathematical modeling”
Immunotherapies are one of the most promising strategies for cancer treatment as they enable achieving stable remission in patients with advance cancer stages.
Seminar “Mathematical modeling helps to better understand the mechanisms B-cell lymphomas acquired resistance to BTK inhibitor treatment”
Chronic activation of B-cell receptor (BCR) signaling via Bruton tyrosine kinase (BTK) is largely considered to be one of the primary mechanisms driving disease progression in B-cell lymphomas, particularly, ABC DLBCL.
